BVNRY
Price
$9.32
Change
-$0.07 (-0.75%)
Updated
Nov 18 closing price
Capitalization
2.21B
Intraday BUY SELL Signals
VRAX
Price
$0.44
Change
-$0.01 (-2.22%)
Updated
Nov 19, 04:52 PM (EDT)
Capitalization
1.95M
Intraday BUY SELL Signals
Interact to see
Advertisement

BVNRY vs VRAX

Header iconBVNRY vs VRAX Comparison
Open Charts BVNRY vs VRAXBanner chart's image
Bavarian Nordic A/S
Price$9.32
Change-$0.07 (-0.75%)
Volume$1.08K
Capitalization2.21B
Virax Biolabs Group
Price$0.44
Change-$0.01 (-2.22%)
Volume$300
Capitalization1.95M
BVNRY vs VRAX Comparison Chart in %
BVNRY
Daily Signal:
Gain/Loss:
VRAX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BVNRY vs. VRAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVNRY is a Hold and VRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BVNRY: $9.30 vs. VRAX: $0.45)
Brand notoriety: BVNRY and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVNRY: 12% vs. VRAX: 10%
Market capitalization -- BVNRY: $2.21B vs. VRAX: $1.95M
BVNRY [@Biotechnology] is valued at $2.21B. VRAX’s [@Biotechnology] market capitalization is $1.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVNRY’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 0 green FA rating(s).

  • BVNRY’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, BVNRY is a better buy in the long-term than VRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVNRY’s TA Score shows that 4 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • BVNRY’s TA Score: 4 bullish, 6 bearish.
  • VRAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VRAX is a better buy in the short-term than BVNRY.

Price Growth

BVNRY (@Biotechnology) experienced а -4.02% price change this week, while VRAX (@Biotechnology) price change was -2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVNRY($2.21B) has a higher market cap than VRAX($1.95M). BVNRY YTD gains are higher at: 6.823 vs. VRAX (-80.089). BVNRY has higher annual earnings (EBITDA): 2.12B vs. VRAX (-6.43M). BVNRY has more cash in the bank: 1.66B vs. VRAX (7.29M). VRAX has less debt than BVNRY: VRAX (380K) vs BVNRY (136M). BVNRY has higher revenues than VRAX: BVNRY (6.46B) vs VRAX (84.9K).
BVNRYVRAXBVNRY / VRAX
Capitalization2.21B1.95M113,573%
EBITDA2.12B-6.43M-32,912%
Gain YTD6.823-80.089-9%
P/E Ratio5.86N/A-
Revenue6.46B84.9K7,603,062%
Total Cash1.66B7.29M22,825%
Total Debt136M380K35,789%
FUNDAMENTALS RATINGS
BVNRY: Fundamental Ratings
BVNRY
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BVNRYVRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
68%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
70%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BVNRY
Daily Signal:
Gain/Loss:
VRAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZBIO37.150.94
+2.60%
Zenas Biopharma Inc.
HBCP53.100.60
+1.14%
Home Bancorp
PAC219.470.33
+0.15%
Grupo Aeroportuario del Pacifico SAB de CV Amer Dep Shares (each rep 10 Ser B shares)
NUKK4.21-0.11
-2.55%
Nukkleus Inc New
SOND0.09-0.01
-8.81%
Sonder Holdings

BVNRY and

Correlation & Price change

A.I.dvisor tells us that BVNRY and GOVX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVNRY and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVNRY
1D Price
Change %
BVNRY100%
-0.21%
GOVX - BVNRY
28%
Poorly correlated
+3.68%
CRMD - BVNRY
24%
Poorly correlated
-0.45%
VRAX - BVNRY
23%
Poorly correlated
-0.62%
DMAC - BVNRY
22%
Poorly correlated
+5.94%
IPHA - BVNRY
21%
Poorly correlated
+0.56%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
-0.62%
ALZN - VRAX
45%
Loosely correlated
-5.73%
CUE - VRAX
34%
Loosely correlated
+0.02%
NTRB - VRAX
31%
Poorly correlated
+0.78%
PTGX - VRAX
30%
Poorly correlated
+0.85%
PYPD - VRAX
28%
Poorly correlated
-1.10%
More